|
OMIM |
Link |
Information gain |
01 |
|
GO
|
[NCBI]
|
0.00155822
|
|
|
PTH
|
[NCBI]
|
0.00108093
|
|
|
myopathy, limb-girdle, with bone fragility
|
[NCBI]
|
0.00092257
|
|
|
hyperimmunoglobulin e-recurrent infection syndrome, autosomal recessive
|
[NCBI]
|
0.000840405
|
|
|
osteogenesis imperfecta, type vi
|
[NCBI]
|
0.000840405
|
|
|
diaphyseal medullary stenosis with malignant fibrous histiocytoma
|
[NCBI]
|
0.000787083
|
|
|
OSCS
|
[NCBI]
|
0.000575369
|
|
|
spinal muscular atrophy, type i, with congenital bone fractures
|
[NCBI]
|
0.000572171
|
|
|
pena-shokeir syndrome, type i
|
[NCBI]
|
0.00040922
|
|
|
VDR
|
[NCBI]
|
0.000368509
|
|
|
osteoporosis, juvenile
|
[NCBI]
|
0.000307133
|
|
|
osteoporosis
|
[NCBI]
|
0.000288463
|
|
|
osteogenesis imperfecta, type i
|
[NCBI]
|
0.000264989
|
|
|
MAS
|
[NCBI]
|
0.000236118
|
|
|
osteogenesis imperfecta, type iv
|
[NCBI]
|
0.000205854
|
|
|
osteogenesis imperfecta, type iii
|
[NCBI]
|
0.000198573
|
|
|
TNFRSF11B
|
[NCBI]
|
0.000119852
|
|
|
osteosclerosis with ichthyosis and fractures
|
[NCBI]
|
0.000114013
|
|
|
electroencephalographic peculiarity: fronto-precentral beta wave groups
|
[NCBI]
|
0.000114013
|
|
|
hyperimmunoglobulin e recurrent infection syndrome, autosomal dominant
|
[NCBI]
|
0.000113013
|
|
|
polycystic bone disease
|
[NCBI]
|
9.15549e-05
|
|
|
osteogenesis imperfecta, type iia
|
[NCBI]
|
8.69029e-05
|
|
|
COL1A1
|
[NCBI]
|
7.88846e-05
|
|
|
LCT
|
[NCBI]
|
7.48218e-05
|
|
|
NN
|
[NCBI]
|
6.7561e-05
|
|
|
GDD
|
[NCBI]
|
6.52515e-05
|
|
|
IBMPFD
|
[NCBI]
|
6.52515e-05
|
|
|
RA
|
[NCBI]
|
6.0017e-05
|
|
|
epiphyseal dysplasia, multiple, with early-onset diabetes mellitus
|
[NCBI]
|
5.98339e-05
|
|
|
KCS
|
[NCBI]
|
5.98339e-05
|
|
|
RNS
|
[NCBI]
|
5.70341e-05
|
|
|
DSMA1
|
[NCBI]
|
5.46555e-05
|
|
|
paget disease, juvenile
|
[NCBI]
|
5.35882e-05
|
|
|
OPPG
|
[NCBI]
|
5.25886e-05
|
|
|
HSAN2
|
[NCBI]
|
5.16487e-05
|
|
|
TMEM16E
|
[NCBI]
|
5.16337e-05
|
|
|
ITGA1
|
[NCBI]
|
5.16337e-05
|
|
|
SEMA7A
|
[NCBI]
|
5.16337e-05
|
|
|
ESR1
|
[NCBI]
|
5.15526e-05
|
|
|
COL1A2
|
[NCBI]
|
4.91878e-05
|
|
|
FAM20C
|
[NCBI]
|
4.8264e-05
|
|
|
HSS
|
[NCBI]
|
4.69541e-05
|
|
|
PDB
|
[NCBI]
|
4.38977e-05
|
|
|
ABS
|
[NCBI]
|
4.33528e-05
|
|
|
homocysteinemia
|
[NCBI]
|
4.33528e-05
|
|
|
CALCR
|
[NCBI]
|
3.94561e-05
|
|
|
SLE
|
[NCBI]
|
3.65325e-05
|
|
|
CLCN7
|
[NCBI]
|
3.64731e-05
|
|
|
mucolipidosis ii
|
[NCBI]
|
3.3477e-05
|
|
|
NPS
|
[NCBI]
|
3.02503e-05
|
|
|
BMP2
|
[NCBI]
|
2.90582e-05
|
|
|
LPI
|
[NCBI]
|
2.85735e-05
|
|
|
SHBG
|
[NCBI]
|
2.81921e-05
|
|
|
CF
|
[NCBI]
|
2.69158e-05
|
|
|
BMP4
|
[NCBI]
|
2.66168e-05
|
|
|
VCP
|
[NCBI]
|
2.44322e-05
|
|
|
APS1
|
[NCBI]
|
2.40575e-05
|
|
|
APOE
|
[NCBI]
|
2.30573e-05
|
|
|
MMP9
|
[NCBI]
|
2.2664e-05
|
|
|
DBA
|
[NCBI]
|
2.17144e-05
|
|
|
NR1I2
|
[NCBI]
|
1.94741e-05
|
|
|
PWS
|
[NCBI]
|
1.63624e-05
|
|
|
ILK
|
[NCBI]
|
1.55561e-05
|
|
|
MFS
|
[NCBI]
|
1.17724e-05
|
|
|
COMP
|
[NCBI]
|
1.01126e-05
|
|
|
GNRH1
|
[NCBI]
|
5.49722e-06
|
|
|
CTGF
|
[NCBI]
|
5.20995e-06
|
|
|
VEGF
|
[NCBI]
|
5.1993e-06
|
|
|
COMT
|
[NCBI]
|
4.86339e-06
|
|
|
TF
|
[NCBI]
|
4.75317e-06
|
|
|
FRAP1
|
[NCBI]
|
4.52289e-06
|
|
|
PRL
|
[NCBI]
|
4.37201e-06
|
|
|
KLK3
|
[NCBI]
|
3.39041e-06
|
|
|
PTHLH
|
[NCBI]
|
2.90915e-06
|
|
|
TNF
|
[NCBI]
|
2.80158e-06
|
|
|
FTD
|
[NCBI]
|
2.57314e-06
|
|
|
EPO
|
[NCBI]
|
2.45335e-06
|
|
|
FMF
|
[NCBI]
|
2.31042e-06
|
|
|
AR
|
[NCBI]
|
8.14606e-07
|
|
|
HGF
|
[NCBI]
|
2.95619e-07
|
|